Day 3, Thursday, March 20th, 2025Thursday, 20 March 2025 - EST/EDT (Eastern Daylight, GMT-4)

This case study explores EMD Serono’s approach to cultivating a strong company culture and its direct impact on team engagement, retention and productivity. The study defines what company culture is and how it shapes daily operations and employee behavior. It highlights the critical role of leadership in fostering and maintaining a positive work environment and demonstrates how a well-established culture drives employee engagement. The case study also examines how a thriving culture contributes to long-term employee retention and increased productivity, providing actionable strategies for organizations aiming to enhance their internal dynamics.

Accumulators, maximizers and alternative fundings programs are just a few of the tools PBMs are using to slash patient access. During this session, receive an update on the impact of these strategies whilst also benchmarking on how your organization can best prepare.

• Analyze the success rate of state-level bans on accumulators and maximizers, including key factors contributing to these outcomes

• Explore opportunities for collaboration between manufacturers and specialty pharmacies to mitigate maximizers

• Identify strategies and unique hub solutions so manufacturers can continue to prioritize patient access and affordability

• Overview copay smoothing to understand what it is, how it differs from traditional Part D benefit structure and its overall mechanics.

• Highlight the advantages of copay smoothing for patients whilst also discussing the challenges and opportunities for health plans and other stakeholder groups.

• Discuss the importance of effective communication and education during open enrollment to ensure that patients are informed about copay smoothing options.

Causal AI is an exciting technology that can enable next-best-action precision and organizational adaptability to support adherence and persistence at the individual patient level. This session will delve into the theory and practice behind Causal AI’s promise, including:

• The differentiating features of Causal AI from other technological advancements and the power of unlocking cause-and-effect relationships behind early patient discontinuation of specialty medications
• How counterfactual analyses can be used to tailor interventions to unique patient needs
• How Causal AI supports transparency and trust across stakeholders supporting the patient journey
• The diversity of datasets and information sources that Causal AI can leverage
• Results from a real-world partnership using Causal AI to deliver actionable insights into the patient journey

Alongside key stakeholders, engage in conversation on how innovative digital platforms and strategies are transforming patient access. Uncover the future of digital solutions for payers and providers to optimize the patient journey.

As the presidential election draws near, the potential impact of a new administration on healthcare legislation looms large. This session explores how upcoming political changes may reshape the regulatory landscape and influence key policies affecting the life sciences sector.

• Delve into the increasing frequency with which industry leaders are being called to testify before Congress, examining whether this trend is likely to continue and what it means for the future

• Analyze the evolving relationship between government and industry and gain insights into how to navigate the shifting political environment on Capitol Hill